Get covered in as little as 24 hours Trusted by thousands of families nationwide
Call Free: 1-888-972-0024

Thyroid disease — including hypothyroidism, hyperthyroidism, and thyroid cancer — is one of the most favorable categories in life insurance underwriting. Well-controlled hypothyroidism on levothyroxine almost universally qualifies for standard or preferred rates. Hyperthyroidism well-controlled on medication or treated with radioactive iodine (RAI) or surgery similarly qualifies at standard rates once stable. Thyroid cancer outcomes depend heavily on type and time since treatment.

What Underwriters Evaluate for Thyroid Disease

Hypothyroidism (Underactive Thyroid) — Well-controlled hypothyroidism with normal TSH on levothyroxine is viewed as a non-event by most underwriters. Standard or preferred rates are achievable. The primary concern is inadequate control — TSH significantly out of range raises questions about compliance and management.
Hyperthyroidism (Overactive Thyroid) — Hyperthyroidism successfully treated with RAI or thyroidectomy (resulting in controlled hypothyroidism) is viewed favorably. Active, uncontrolled hyperthyroidism carries cardiovascular risk (particularly atrial fibrillation) and triggers higher scrutiny.
Thyroid Cancer History — Papillary thyroid cancer (the most common type) has an excellent prognosis and is generally viewed very favorably by underwriters. Standard rates are often achievable within 1–2 years of treatment. Follicular thyroid cancer has a slightly less favorable profile. Medullary and anaplastic thyroid cancer are much more restrictive.
TSH Level — For hypothyroidism, a normal TSH range (typically 0.4–4.0 mIU/L) on stable levothyroxine dosing is the key metric. Significantly elevated or suppressed TSH raises questions about control, even without other complications.

Thyroid Condition: General Underwriting Outlook

Thyroid Condition Typical Rating Best Achievable Notes
Hypothyroidism, controlled on levothyroxine, normal TSH Standard to Standard Plus Preferred Plus at many carriers Treated as essentially normal risk by most underwriters
Hyperthyroidism, treated with RAI or surgery, stable Standard Standard Plus once stable 6–12 months of stability post-treatment typically required
Papillary thyroid cancer, treated, 1–2 years post-treatment Standard to Table 2 Standard at select carriers after 1 year Excellent prognosis; most favorable cancer underwriting scenario
Active uncontrolled hyperthyroidism Postponement Postponement until controlled Cardiovascular risk from uncontrolled hyperthyroidism triggers postponement

Guidelines current as of 2025–2026. Verify with us before applying.

Thyroid Condition? You Likely Qualify at Standard Rates.

Well-controlled thyroid disease is one of the most insurable conditions. We confirm your best rate before any application is submitted.

Call 1-888-972-0024


Browse All High-Risk Conditions

Atrial Fibrillation | Heart Attack / Heart Disease | High Blood Pressure | Stroke / TIA | Diabetes | Obesity | COPD / Emphysema | Sleep Apnea | Lupus | Multiple Sclerosis | Rheumatoid Arthritis | Kidney Disease (CKD) | Hepatitis B & C | Crohn’s Disease | Ulcerative Colitis | Cancer History | Anxiety / Depression | Bipolar Disorder | Epilepsy | PTSD | HIV / AIDS | DUI / DWI | Drug Use / Abuse | Marijuana Use | Aviation / Pilots

Understanding Your Rating: Life Insurance Risk Classifications | Table Ratings Explained (B–J) | Flat Extra Ratings

Authoritative Resources: Life insurance underwriting practices are regulated by the NAIC. Insurers may check your health history through the MIB Group — you can request your free annual MIB report at mib.com.

Frequently Asked Questions

Can I get life insurance with hypothyroidism?

Yes — and typically without any rate impact at all. Well-controlled hypothyroidism with a normal TSH level on stable levothyroxine dosing is treated by most underwriters as essentially standard risk. Preferred Plus rates are achievable for hypothyroid applicants who are otherwise healthy. The condition is one of the most benign in life insurance underwriting when controlled.

Does taking thyroid medication affect my life insurance rates?

No. Levothyroxine for hypothyroidism does not negatively affect your rate class. Carriers evaluate the outcome — your TSH level and overall health — not the fact that medication is required to achieve it. An otherwise healthy applicant on levothyroxine with a normal TSH is treated identically to an applicant without thyroid disease at most carriers.

Can I get life insurance after thyroid cancer?

Yes, in most cases. Papillary thyroid cancer — the most common type — has an excellent prognosis and is one of the most favorably underwritten cancer histories. Standard rates are often achievable within one to two years of successful treatment with no evidence of recurrence. Follicular thyroid cancer is also generally favorable. Medullary and anaplastic thyroid cancers are much more restrictive.

How does hyperthyroidism affect life insurance underwriting?

Active, uncontrolled hyperthyroidism carries cardiovascular risk — particularly atrial fibrillation — that causes underwriters to postpone applications until control is achieved. Hyperthyroidism successfully treated with radioactive iodine or thyroidectomy, resulting in stable hypothyroidism controlled with levothyroxine, is viewed very favorably. Most carriers require six to twelve months of stable post-treatment thyroid function before making their best offers.

What TSH level do life insurance underwriters want to see?

Underwriters want to see a TSH within the normal reference range, typically 0.4 to 4.0 mIU per liter, on a stable levothyroxine dose. A significantly elevated TSH suggests undertreated hypothyroidism. A suppressed TSH raises concern about hyperthyroidism or over-replacement. Consistent normal TSH values over the past one to two years is the most favorable presentation.

Ready to Protect What Matters Most?

Get your free, no-obligation quote in under 60 seconds. Our advisors are available 7 days a week, 9am–9pm.